This comprehensive continuing education program delves into the complexities of HCM, an autosomal dominant genetic disorder marked by increased left ventricular hypertrophy. This condition can lead to significant health complications, such as heart failure, arrhythmias, stroke, and sudden cardiac death. Drawing from the latest insights from the 2024 multi-society HCM guidelines, this program aims to enhance clinician knowledge in identifying, diagnosing, and treating both obstructive and non-obstructive HCM. Additionally, the tethered course will highlight some of the key findings from a recent social media program for patients, offering critical insights into the experience of caregivers and patients with HCM and how these perspectives can inform clinical care.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/cardiology/20241119/hypertrophic-cardiomyopathy/overview
- Start Date: 2024-11-22 06:00:00
- End Date: 2024-11-22 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
- Commercial Support: Source: Bristol Myers Squibb - Amount: 132025.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all